Biomarkers clinical relevance in cancer: Emphasis on breast cancer and prostate cancer

Riyaz Mahammad Basha, Cheryl H. Baker, Maen Abdelrahim

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Cancer remains a major health problem in the world due to the dramatic increase in the number of cancer-related deaths in recent years. Biomarkers are biological candidates that are altered due to disease condition and can serve as indicators of the disease process. Identification of clinically useful biomarkers is very critical in cancer therapy especially for the early detection of disease which can reduce mortality and increase survival of life. Despite the serious concern and urgent need for the discovery of candidate tumor markers, the outcomes in developing credible biomarkers are remarkably low. Due to recent emergence of novel technologies, scientists are extensively conducting comprehensive analyses using multiple approaches including genomics and proteomics to address the issues related to low success rate and more disappointments in developing tumor markers with clinical significance. Both the government and public sectors are using their resources to focus on multiple approaches which could foster developing new biomarkers for diagnosis and early detection of cancer, thereby facilitating better understanding of cancer pathogenesis and advanced cancer care in a reasonable time frame. This review will focus on the relevance of biomarkers in cancer with a special emphasis on breast cancer and prostate cancer.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalCurrent Trends in Biotechnology and Pharmacy
Volume3
Issue number1
StatePublished - 27 Mar 2009

Fingerprint

Prostatic Neoplasms
Biomarkers
Breast Neoplasms
Tumor Biomarkers
Neoplasms
Public Sector
Genomics
Early Detection of Cancer
Proteomics
Early Diagnosis
Technology
Mortality
Health
Therapeutics

Keywords

  • Biomarkers
  • Breast cancer
  • Disease therapy
  • Prostate cancer

Cite this

@article{3fc85ebbdd0c4a0e9c1f067ea1efd4b4,
title = "Biomarkers clinical relevance in cancer: Emphasis on breast cancer and prostate cancer",
abstract = "Cancer remains a major health problem in the world due to the dramatic increase in the number of cancer-related deaths in recent years. Biomarkers are biological candidates that are altered due to disease condition and can serve as indicators of the disease process. Identification of clinically useful biomarkers is very critical in cancer therapy especially for the early detection of disease which can reduce mortality and increase survival of life. Despite the serious concern and urgent need for the discovery of candidate tumor markers, the outcomes in developing credible biomarkers are remarkably low. Due to recent emergence of novel technologies, scientists are extensively conducting comprehensive analyses using multiple approaches including genomics and proteomics to address the issues related to low success rate and more disappointments in developing tumor markers with clinical significance. Both the government and public sectors are using their resources to focus on multiple approaches which could foster developing new biomarkers for diagnosis and early detection of cancer, thereby facilitating better understanding of cancer pathogenesis and advanced cancer care in a reasonable time frame. This review will focus on the relevance of biomarkers in cancer with a special emphasis on breast cancer and prostate cancer.",
keywords = "Biomarkers, Breast cancer, Disease therapy, Prostate cancer",
author = "Basha, {Riyaz Mahammad} and Baker, {Cheryl H.} and Maen Abdelrahim",
year = "2009",
month = "3",
day = "27",
language = "English",
volume = "3",
pages = "1--7",
journal = "Current Trends in Biotechnology and Pharmacy",
issn = "0973-8916",
publisher = "Association of Biotechnology and Pharmacy",
number = "1",

}

Biomarkers clinical relevance in cancer : Emphasis on breast cancer and prostate cancer. / Basha, Riyaz Mahammad; Baker, Cheryl H.; Abdelrahim, Maen.

In: Current Trends in Biotechnology and Pharmacy, Vol. 3, No. 1, 27.03.2009, p. 1-7.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Biomarkers clinical relevance in cancer

T2 - Emphasis on breast cancer and prostate cancer

AU - Basha, Riyaz Mahammad

AU - Baker, Cheryl H.

AU - Abdelrahim, Maen

PY - 2009/3/27

Y1 - 2009/3/27

N2 - Cancer remains a major health problem in the world due to the dramatic increase in the number of cancer-related deaths in recent years. Biomarkers are biological candidates that are altered due to disease condition and can serve as indicators of the disease process. Identification of clinically useful biomarkers is very critical in cancer therapy especially for the early detection of disease which can reduce mortality and increase survival of life. Despite the serious concern and urgent need for the discovery of candidate tumor markers, the outcomes in developing credible biomarkers are remarkably low. Due to recent emergence of novel technologies, scientists are extensively conducting comprehensive analyses using multiple approaches including genomics and proteomics to address the issues related to low success rate and more disappointments in developing tumor markers with clinical significance. Both the government and public sectors are using their resources to focus on multiple approaches which could foster developing new biomarkers for diagnosis and early detection of cancer, thereby facilitating better understanding of cancer pathogenesis and advanced cancer care in a reasonable time frame. This review will focus on the relevance of biomarkers in cancer with a special emphasis on breast cancer and prostate cancer.

AB - Cancer remains a major health problem in the world due to the dramatic increase in the number of cancer-related deaths in recent years. Biomarkers are biological candidates that are altered due to disease condition and can serve as indicators of the disease process. Identification of clinically useful biomarkers is very critical in cancer therapy especially for the early detection of disease which can reduce mortality and increase survival of life. Despite the serious concern and urgent need for the discovery of candidate tumor markers, the outcomes in developing credible biomarkers are remarkably low. Due to recent emergence of novel technologies, scientists are extensively conducting comprehensive analyses using multiple approaches including genomics and proteomics to address the issues related to low success rate and more disappointments in developing tumor markers with clinical significance. Both the government and public sectors are using their resources to focus on multiple approaches which could foster developing new biomarkers for diagnosis and early detection of cancer, thereby facilitating better understanding of cancer pathogenesis and advanced cancer care in a reasonable time frame. This review will focus on the relevance of biomarkers in cancer with a special emphasis on breast cancer and prostate cancer.

KW - Biomarkers

KW - Breast cancer

KW - Disease therapy

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=62849110598&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:62849110598

VL - 3

SP - 1

EP - 7

JO - Current Trends in Biotechnology and Pharmacy

JF - Current Trends in Biotechnology and Pharmacy

SN - 0973-8916

IS - 1

ER -